Thursday 6 October 2022 – 07.00am – 08.00am
Breakfast 1 – da Vinci prostatectomy – simple to complex, and in between.
Sponsored by Device Technologies
Dr CS Loh qualified in Medicine with Honours from Liverpool University in the United Kingdom in 1983. He obtained his Fellowship in General Surgery from the Edinburgh Royal College of Surgeons in 1987 and the Fellowship in Urological Surgery in 1996. He was previously an Associated Professor in Urology in The University of Malaya and is a past president of the Malaysian Urological Association.
Breakfast will be served during this symposia. Limited to 80 attendees
Breakfast 2 – XTANDI™ (enzalutamide) in the evolving treatment landscape of advanced prostate cancer.
Sponsored by Astellas
An expert presentation and clinical case discussions will address the role of XTANDI™ in combination therapies for prostate cancer. Attendees of this symposium will learn about the importance of early treatment intensification for patients with mHSPC, the multiple benefits of XTANDI™ treatment for a broad prostate cancer patient population, and the differentiating points for using XTANDI™ as first-line treatment for patients with mHSPC and CRPC.
Breakfast will be served during this session
Limited to 100 attendees
Thursday 6 October 2022 – 5.15pm – 6.15pm
Evening Symposia – Minimally Invasive BPH Treatment- an International Perspective.
Sponsored by Teleflex
Dr Brian Mazzarella will speak about his experience in treating patients with BPH in the US. He practices in Austin, Texas, and specialises in the treatment of Benign Prostatic Hyperplasia. Please join Teleflex for an interactive panel discussion, moderated by Dr Eric Chung, where regional Urologists will share their opinions in the field of BPH
Canapés will be served during this session
Friday 7 October 2022 – 07.00am – 08.00am
Breakfast Symposia – Advances in Stone Management and Minimally Invasive Therapy for BPH – how Soltive and iTind are providing new treatment options.
Olympus Urology has recently introduced the iTind prostatic urethra reshaping device and the Soltive Laser into various markets in the Asia Pacific. Dr Pascal Mancuso and Dr Simon Bariol from Sydney will be sharing with us their experiences in Endo Urology with these cutting-edge technologies.
Breakfast will be served during this session
Limited to 100 attendees